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ABSTRACT 1 
Extracellular DNA (eDNA) has been identified in the matrix of many different mono-2 
species biofilms in vitro, including some of those produced by oral bacteria. In many cases, eDNA 3 
stabilizes the structure of mono-species biofilms. Here, we aimed to determine whether eDNA is 4 
an important component of natural mixed-species oral biofilms such as plaque on natural teeth or 5 
dental implants. To visualize eDNA in oral biofilms, approaches for fluorescently staining eDNA 6 
with either anti-DNA antibodies or an ultrasensitive cell-impermeant dye, YOYO-1, were first 7 
developed using E. faecalis, an organism that has previously been shown to produce extensive 8 
eDNA structures within biofilms. Oral biofilms were modelled as in vitro ‘microcosms’ on glass 9 
coverslips inoculated with the natural microbial population of human saliva and cultured statically 10 
in artificial saliva medium. Using antibodies and YOYO-1, eDNA was found to be distributed 11 
throughout microcosm biofilms, and was particularly abundant in the immediate vicinity of cells. 12 
Similar arrangements of eDNA were detected in biofilms on crowns and overdenture abutments 13 
of dental implants that had been recovered from patients during the restorative phase of treatment, 14 
and in subgingival dental plaque of periodontitis patients, indicating that eDNA is a common 15 
component of natural oral biofilms. In model oral biofilms, treatment with a DNA-degrading 16 
enzyme, NucB from Bacillus licheniformis, strongly inhibited the accumulation of biofilms. The 17 
bacterial species diversity was significantly reduced by treatment with NucB and particularly 18 
strong reductions were observed in the abundance of anaerobic, proteolytic bacteria such as 19 
Peptostreptococcus, Porphyromonas and Prevotella. Pre-formed biofilms were not significantly 20 
reduced by NucB treatment, indicating that eDNA is more important or more exposed during the 21 
early stages of biofilm formation. Overall, these data demonstrate that dental plaque eDNA is 22 




Dental caries, periodontitis and peri-implantitis are caused by the accumulation of 25 
microbial biofilms (plaque) on tooth or implant surfaces. Any individual harbors approximately 26 
100-300 different species/phylotypes from a pool of around 700 common oral bacteria (Chen et 27 
al. 2010; Zhang et al. 2015). These complex communities are held together by a matrix of 28 
extracellular polymers, including polysaccharides, lipids, proteins and nucleic acids. Attempts 29 
have been made to control biofilms by targeting extracellular polysaccharides using enzymes such 30 
as glucanases or dispersin B (Otsuka et al. 2015; Ragunath et al. 2016). However, even relatively 31 
simple mixed-species biofilms can contain many different polysaccharides and the complexity of 32 
polysaccharide linkages limits the efficacy of individual enzymes for degrading biofilm matrices. 33 
Consequently, research has focused on other structurally relevant extracellular biofilm molecules 34 
that may be more susceptible to degradation and, in particular, extracellular DNA (Okshevsky et 35 
al. 2014). 36 
Extracellular DNA (eDNA) stabilizes many different laboratory-grown mono-species 37 
biofilms (Jakubovics et al. 2013; Okshevsky and Meyer 2015). Biofilm matrix eDNA can 38 
potentially be targeted by bacterial DNases such as NucB from Bacillus licheniformis, which can 39 
be produced cost-effectively in microbial expression systems (Rajarajan et al. 2012). However, at 40 
present little is known about the role of eDNA in mixed-species biofilms and even the detection 41 
of eDNA in complex natural biofilm communities has proven challenging. Using fluorescent dyes 42 
and DNase treatment, eDNA has been detected in activated sludge flocs (Dominiak et al. 2011). 43 
There is also circumstantial evidence that eDNA is present in dental plaque. For example, 44 
photochemical cross-linking of extracellular DNA with propidium monoazide reduced the 45 
concentration of PCR-amplifiable S. mutans DNA in dental plaque by approximately three-fold, 46 
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indicating that only one third of S. mutans DNA was protected within viable cells (Yasunaga et al. 47 
2013). Extracellular DNA has been directly observed in mono-species S. mutans biofilms and is 48 
actively released from cells via membrane vesicles (Liao et al. 2014). Systems for the uptake and 49 
incorporation of free DNA are widely present in oral bacteria including Streptococcus spp. and 50 
Porphyromonas spp., indicating that these microorganisms are exposed to eDNA at times within 51 
their natural environments (Tribble et al. 2012; Jakubovics et al. 2014). Indeed, there is extensive 52 
evidence from genome sequences that DNA has been horizontally transferred between oral 53 
bacteria (Do et al. 2011).  54 
We have recently shown that extracellular matrix material is abundant in subgingival dental 55 
plaque in the form of strands and meshwork structures that appear similar to “yarn-like” threads 56 
and eDNA lattice structures, or “sweaters” observed within in vitro Enterococcus faecalis biofilms 57 
(Barnes et al. 2012; Holliday et al. 2015). Here, we aimed to visualize eDNA in natural oral biofilm 58 
samples using specific antibodies and an ultrasensitive dye. In addition, the possible structural role 59 
of eDNA was assessed in model dental plaque biofilms. 60 
 61 
 62 
MATERIALS & METHODS 63 
Detailed methods are given in the Appendix. 64 
Clinical specimen collection 65 
 Study participants were recruited from the Periodontology consultation clinics of the 66 
Newcastle Dental Hospital. Ethical approval was obtained from the Yorkshire and Humber 67 
Research Ethics Committee (Reference 14/YH/0145). Dental implants and periodontally affected 68 
teeth were stored in PBS for up to 3 h after collection. Teeth were sectioned using a dental air 69 
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turbine handpiece under water cooling. Saliva was collected as described by Nance et al. (2013). 70 
In brief, parafilm-stimulated whole saliva was collected on ice from at least five healthy adults 71 
who were non-smokers, had not consumed food or hot drinks for 2 h, and had not taken antibiotics 72 
for at least two weeks prior to donation. Individual saliva samples or pooled saliva was mixed with 73 
glycerol in a 75%/25% ratio within 2 h of collection and stored at -80°C. 74 
 75 
Routine culture of bacteria and biofilm growth 76 
E. faecalis JH2-2 was routinely grown in BHY (37 g/L Brain Heart Infusion and 5 g/L 77 
yeast extract, Melford, Ipswich, UK). Microcosm biofilms were inoculated with human saliva, 78 
diluted 1:100 in artificial saliva (Pratten 2007). In some cases, glucose in the artificial saliva was 79 
replaced with 2% (w/v) sucrose. Biofilms were cultured statically on plastic or glass surfaces (see 80 
Appendix) for 24 h at 37°C either aerobically (with sucrose) or anaerobically.  81 
 82 
Production and purification of NucB 83 
Recombinant NucB from Bacillus licheniformis DSM13 was produced in Bacillus subtilis 84 
NZ8900 using the SURE expression system as previously described (Nijland et al. 2010) and 85 
purified as described in the Appendix. 86 
 87 
Fluorescent staining 88 
Biofilms were rinsed with PBS prior to fluorescent staining. To stain eDNA, 89 
immunofluorescent labelling was performed as described by Barnes et al. (2012). Alternatively, 90 
biofilm-harboring substrata were incubated with 2.4 nM YOYO-1 (Life Technologies, Carlsbad, 91 
California, United States) for 10 min at 20°C. Bacterial cell membranes were stained with 1 µg ml-1 92 
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Nile Red (Sigma-Aldrich, St. Louis, Missouri, United States) or with 2.9 µg ml-1 FM5-95 (Life 93 
Technologies). Microcosm biofilms were stained with Live/Dead BacLightTM (Molecular Probes, 94 
Eugene, Oregon, USA). Biofilms were visualized by confocal laser scanning microscopy (CLSM) 95 
or by epifluorescent microscopy (see Appendix). 96 
 97 
Scanning electron microscopy 98 
Samples for field emission scanning electron microscopy (FESEM) imaging were fixed in 99 
2% (w/v) glutaraldehyde in Sorenson’s Phosphate buffer and dehydrated through a series of 100 
ethanol (Holliday et al. 2015). A FEI Helios NanoLab Dual Beam MK 2 field emission microscope 101 
was used for imaging as previously described (Holliday et al. 2015). 102 
 103 
NucB treatment of biofilms 104 
To assay the inhibitory effects of NucB on biofilm growth, 5 µg ml-1 crude or purified 105 
NucB was included with the growth medium during biofilm formation. Alternatively, 5 µg ml-1 106 
NucB in 50 mM Tris-HCl (pH 8.0) was added to biofilms after growth and incubated at 37°C for 107 
1 h.  Biofilms were quantified by crystal violet staining (see Appendix). All assays were performed 108 
in triplicate, and results shown are means and standard errors from three independent experiments. 109 
Statistical significance of differences between groups was assessed by one-way ANOVA with 110 
Tukey’s post-hoc test. 111 
 112 
DNA extraction and microbial population analysis 113 
For microbial population analysis, biofilms were cultured on the surface of 6 well plates in 114 
the presence or absence of purified NucB (see Appendix). DNA was extracted using the  115 
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MasterPure™ Gram Positive DNA Purification Kit (Epicentre® Biotechnologies, Madison, USA) 116 
as described previously (Shields et al. 2013). Next Generation Sequencing was performed on the 117 
Illumina MiSeq platform by MR DNA (Shallowater, TX, USA). See Appendix for more details.  118 




Visualization of eDNA in E. faecalis biofilms 121 
Techniques for visualizing eDNA were initially developed using E. faecalis biofilms since 122 
these are well-known to contain extensive eDNA (Barnes et al., 2012). Biofilms were grown on 123 
glass coverslips and eDNA was visualized using fluorophore-conjugated anti-DNA antibodies. 124 
Using CLSM, eDNA was concentrated in punctate foci protruding from the base of the biofilm to 125 
the surface (Fig. 1A). These bright foci were consistently found throughout the biofilm suggesting 126 
that eDNA was present within the matrix. There was no staining in the absence of either primary 127 
or secondary antibody (data not shown). To visualize eDNA in viable (unfixed) biofilms with 128 
minimal sample processing, the ultrasensitive cell-impermeant fluorescent DNA dye YOYO-1 129 
was used. With this approach, eDNA appeared as web-like structures localized outside cells 130 
(Fig. 1B). A few bright foci were also observed within biofilms. To obtain increased resolution, 131 
biofilms were gently harvested by scraping and placed on agarose pads for visualization by 132 
epifluorescent microscopy (Fig. 1C). In these images, E. faecalis cells were surrounded by eDNA. 133 
YOYO-1 staining was almost always restricted to the outside of the cells, and YOYO-1 staining 134 
appeared similar to that in intact biofilms (Fig. 1B). To ensure that YOYO-1 was specifically 135 
staining eDNA, biofilms were treated with the DNase enzyme NucB prior to staining (Fig. 1C 136 
lower panel). By quantitative image analysis, the YOYO-1 signal was significantly decreased by 137 
>70% after NucB treatment (p<0.05).  138 
 139 
Extracellular DNA in salivary microcosm models of dental plaque  140 
To assess immunofluorescence and YOYO-1 staining for detection of eDNA in mixed-141 
species biofilms, microcosms of human salivary bacteria were cultured anaerobically in vitro on 142 
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glass coverslips as a model of subgingival dental plaque growing in the low oxygen environment 143 
of periodontal pockets. Once again, immunofluorescent labelling showed punctate areas of bright 144 
green fluorescence, indicative of eDNA, throughout the biofilm (Fig. 2A). Staining with YOYO-1 145 
also gave rise to punctate green fluorescence co-localized to areas of cells (Fig. 2B). At higher 146 
resolution, the majority of the YOYO-1 stain was clearly outside cells (Fig. 2C). Similar to E. 147 
faecalis biofilms, there were a few very bright regions that appeared to represent intracellular 148 
YOYO-1 dye.  149 
 150 
Extracellular DNA in dental plaque from ex vivo specimens 151 
Samples of natural plaque from extracted teeth and implants were collected from the 152 
periodontology clinics for eDNA analysis. Using FESEM, it was shown that tooth samples 153 
contained extensive subgingival dental plaque (Fig. 3A). Biofilms consisted of many different 154 
microbial cells with distinct morphologies surrounded by extracellular material (Fig. 3A, i). 155 
Interestingly, numerous cells appeared to have holes in their walls while being held in place by 156 
matrix material (Fig. 3A, ii). The matrix also included many small vesicle-like structures (Fig. 3A, 157 
iii). 158 
Direct visualization of biofilms on extracted teeth and implants was not possible due to the 159 
uneven nature of the substratum and excessive autofluorescence from the substratum material. 160 
Therefore, biofilms were harvested by scraping and visualized under high resolution 161 
epifluorescence microscopy. Biofilms were detected on provisional resin composite crowns and 162 
overdenture abutments recovered during the restorative phase of implant treatment (Fig. 3B). In 163 
general, biofilms on implant crowns were more abundant and appeared to harbor more bacteria 164 
than those on overdenture abutments. Nevertheless, using YOYO-1, eDNA was clearly visible in 165 
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both types of biofilm. Subgingival dental plaque on the surface of teeth extracted for periodontitis 166 
contained many different cell morphologies along with extracellular material that was stained with 167 
YOYO-1 (Fig. 3C).  Treatment with NucB reduced the extent of green staining dramatically, 168 
supporting that the YOYO-1 specifically stained eDNA. 169 
 170 
Importance of eDNA for biofilm structure 171 
Initially, the activity of NucB against microcosm biofilms was assessed using crude NucB 172 
preparations. Saliva from six different volunteers was used as the source of microbial inoculae and 173 
biofilms were cultured either aerobically in 2% sucrose as a cariogenic biofilm model, or 174 
anaerobically to mimic the low oxygen tension of the periodontal pocket environment. Inhibition 175 
of biofilm formation was assessed by including NucB during biofilm growth. Alternatively, 176 
dispersal of pre-formed biofilms was monitored by incubating pre-formed biofilms with NucB. No 177 
aerobic, sucrose-grown biofilms were inhibited in the presence of NucB and only one biofilm was 178 
significantly dispersed (Fig. S1). In several cases, anaerobically cultured biofilms were 179 
significantly inhibited or dispersed by NucB (data not shown). To ensure that impurities in the 180 
enzyme preparation were not responsible for the observed effects on anaerobic biofilms, NucB 181 
was purified by sequential chromatography. Purified NucB had DNase activity but no detectable 182 
RNase or protease activity (Fig. S2). Incubation with NucB significantly (p<0.05) reduced biofilm 183 
growth in microcosms from four distinct salivary inoculae and from pooled saliva (Fig. 4A and 184 
B). Treatment of pre-formed biofilms with NucB resulted in much smaller reductions in biofilm 185 
biomass that were not statistically significant (Fig. 4B).  186 
To determine whether NucB selectively excluded certain micro-organisms from biofilms, 187 
DNA was extracted from biofilms cultured in the presence or absence of NucB and analyzed by 188 
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next generation sequencing. The microbial load was much lower in the presence of NucB (Fig. 5). 189 
The bacterial diversity within each sample (alpha diversity) was significantly reduced in NucB-190 
treated biofilms compared with controls (Fig. S3). Control samples formed a discrete cluster by 191 
principle co-ordinates analysis that was clearly separated from NucB-treated samples (Fig. S4). 192 
Sixteen genera were present at >1% of the total reads (Fig. 5A). Following NucB treatment, the 193 
proportions of all genera except Actinomyces, Aggregatibacter and Fusobacterium were 194 
significantly changed (p<0.05). Populations cultured in the presence of NucB were enriched in 195 
Streptococcus and Veillonella species, whereas Haemophilus, Neisseria, Peptostreptococcus, 196 
Porphyromonas and Prevotella were dramatically reduced with NucB treatment. Haemophilus 197 
parainfluenzae was the most abundant species in the absence of NucB (18% of the population), 198 
but was reduced by an order of magnitude in NucB-treated biofilms. Neisseria subflava was also 199 
reduced by NucB treatment, from 11% to 1% of the total population. By contrast, Streptococcus 200 
salivarius, Streptococcus parasanguinis, Veillonella parvula and Veillonella dispar were 201 
proportionally increased in populations treated with NucB (Fig. 5B). 202 
 203 
DISCUSSION 204 
Exopolysaccharides in cariogenic dental plaque have been the subject of intense research 205 
over many decades (Koo et al. 2013). However, the composition of matrices of non-cariogenic 206 
oral biofilms is relatively poorly understood. Oral streptococci such as S. gordonii, S. sanguinis 207 
and S. mutans produce eDNA in laboratory mono-cultures (Kreth et al. 2009; Liao et al. 2014). 208 
Here, eDNA was also detected in mixed-species oral biofilms including subgingival dental plaque 209 
and plaque on the surface of the provisional resin composite crowns and overdenture abutments of 210 
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dental implants. We propose that eDNA is likely a ubiquitous component of biofilms throughout 211 
the oral cavity. 212 
Ideally, techniques to visualize eDNA in natural biofilms should be non-disuptive and 213 
highly specific. Recently, FESEM has been applied in combination with anti-DNA antibodies or 214 
DNase enzymes to show the structure of eDNA in E. faecalis or S. mutans biofilms (Barnes et al. 215 
2012; Liao et al. 2014). Extracellular DNA appeared as long strands, described as ‘yarn-like’ 216 
structures, or in weblike mats likened to ‘sweaters’ (Barnes et al. 2012). We have observed both 217 
yarn-like and sweater structures in the matrices of subgingival dental plaque using FESEM 218 
(Fig. 3A). Despite numerous attempts, we were not able to label these with specific anti-DNA 219 
antibodies in conjunction with FESEM (Holliday et al. 2015). Therefore, we have developed 220 
fluorescence-based methods to stain eDNA in natural biofilms. Using these techniques, eDNA was 221 
detected in all biofilms that were studied here.  222 
High resolution images showing eDNA surrounding cells were obtained by gently scraping 223 
the biofilms and transferring them to agar pads. In optimisation experiments on model single-224 
species or microcosm biofilms, no qualitative differences were observed in the amount of eDNA 225 
present in intact biofilms compared with harvested biofilms. In addition, the eDNA appeared 226 
closely localized around cells in both intact and harvested model biofilms. Therefore, apparently 227 
harvesting biofilms did not dramatically alter the nature of the eDNA. Treatment of biofilms with 228 
NucB significantly reduced eDNA but did not completely eliminate it. It is possible that eDNA 229 
was protected to some extent by binding to protein or carbohydrates. Previous studies have shown 230 
that eDNA produced by oral bacteria including S. gordonii and Porphyromonas gingivalis 231 
associates with DNA binding proteins such as DNAIIB (Rocco et al. 2016). In Staphylococcus 232 
aureus, beta toxin becomes covalently linked to eDNA, forming a nucleoprotein matrix (Huseby 233 
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et al. 2010). The Pseudomonas aeruginosa polysaccharide Pel cross-links eDNA by ionic 234 
interactions (Jennings et al. 2015), and in the presence of neutrophils eDNA is apparently protected 235 
from DNase digestion by association with F-actins or histones (Parks et al. 2009). It is possible 236 
that similar mechanisms occur in oral biofilms. Alternatively, it is possible that extracellular 237 
proteases in mature biofilms may have degraded NucB. Work is ongoing to identify the fate of 238 
NucB following addition to biofilms. 239 
In all samples studied here, there was evidence that YOYO-1 occasionally entered cells. It 240 
is likely that these cells were compromised, since YOYO-1 does not cross intact membranes (Pham 241 
et al. 2011). In fact, FESEM images showed that some cells in the biofilm were open at one pole, 242 
and likely would not have excluded dyes. Indeed, it is possible that controlled cell lysis may be a 243 
mechanism for the release of DNA into the biofilm matrix. In E. faecalis, cell lysis is actively 244 
induced in a proportion of the population as a mechanism for releasing DNA into the surrounding 245 
milieu (Thomas et al. 2009). More recently it has been shown that subpopulations of P. aeruginosa 246 
undergo explosive cell lysis, releasing DNA either in free form or encapsulated within membrane 247 
vesicles (Turnbull et al. 2016). Membrane vesicles were also observed in our FESEM images, and 248 
these may have been the remnants of explosive lysis of cells. It is possible that eDNA may also 249 
enter the biofilm without cell lysis, as has been demonstrated in E. faecalis and S. gordonii mono-250 
cultures (Itzek et al. 2011; Barnes et al. 2012). Neisseria gonorrhoaea releases DNA through a 251 
type IV secretion system (Hamilton et al. 2005), and homologues may be present in oral bacteria. 252 
We are currently developing methods to purify eDNA without lysing bacterial cells in order to 253 
investigate the size and sequence of eDNA fragements within natural oral biofilms.  254 
Using the DNase enzyme NucB, it was shown that eDNA plays an important structural role 255 
during the formation of oral biofilms. Biofilms cultured aerobically in sucrose were relatively 256 
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insensitive to NucB, presumably because extracellular polysaccharides stabilized the matrix (Koo 257 
et al. 2013). Pre-formed biofilms cultured anaerobically were also not significantly reduced by 258 
NucB treatment. By contrast, the formation of anaerobic biofilms was strongly inhibited in the 259 
presence of NucB (Figure 4). The sensitivity of anaerobic biofilms to DNase treatment is similar 260 
to that observed in mono-species P. aeruginosa biofilms, which are sensitive to DNase I only 261 
during the early stages of biofilm formation (Whitchurch et al. 2002). It is possible that eDNA is 262 
important during the initial stages of attachment and colonization. Alternatively, eDNA may 263 
become resistant to DNase enzymes during biofilm maturation by forming complexes with other 264 
macromolecules.  265 
 Interestingly, we observed species-specific effects of NucB during initial colonization of 266 
oral biofilms and the microbial diversity in biofilms was significantly reduced by NucB treatment. 267 
To our knowledge, this is the first demonstration that DNase treatment can cause marked shifts in 268 
the microbial composition of mixed-species oral biofilms. In vitro, biofilms formed by different 269 
species and even different strains within a species show marked differences in their sensitivities to 270 
DNase enzymes (Lappann et al. 2010; Shields et al. 2013). It is notable that well-known pioneer 271 
colonizers of dental plaque such as streptococci and veillonellae were enriched in biofilms grown 272 
in the presence of NucB. Pioneer colonizers produce cell surface adhesins that recognize protein 273 
or glycoprotein receptors in the salivary pellicle and mediate adhesion to tooth surfaces (Nobbs et 274 
al. 2011). Therefore, these species may be less reliant on eDNA for adhesion than later colonizers. 275 
By selectively targeting certain species, NucB may reduce the capacity for synergistic 276 
interbacterial interactions or for the establishment of gradients of nutrients or oxygen, which are 277 
essential for biofilm development and maturation. Consequently, addition of NucB during dental 278 
plaque formation may have profound effects on the overall biofilm structure. 279 
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In summary, this study provides clear evidence that eDNA is present in oral biofilms 280 
including plaque on natural teeth and dental implants. Extracellular DNA represents a potential 281 
target for biofilm control and for the exclusion of potential pathogens from plaque. Our data 282 
indicate that DNases may be more effective for controlling biofilms in areas of low oxygen tension 283 
such as subgingival dental plaque than for cariogenic supragingival plaque formed from a high-284 
sugar diet, which is characterized by an abundance of exopolysaccharides. Human DNase I is 285 
already used for the treatment of cystic fibrosis, demonstrating that DNases may have potential for 286 
biofilm control within the human body. Further studies are now required to determine the role of 287 
eDNA in the struture and stability of mature oral biofilms, and to assess the potential for DNase 288 
enzymes to be used in oral healthcare applications. 289 
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Figure 1: Visualization of eDNA in E. faecalis biofilms. (A) Immunofluorescent labelling of E. 
faecalis biofilm with an α-DNA antibody (green). Nile Red was included to highlight cell 
membrane (red). A 3D rendering of the overlay image is shown on the left. The right panel shows 
Alexa flour-antibody labelled eDNA forming punctate foci protruding from the base of the biofilm. 
(B) Fluorescent staining of E. faecalis biofilm with YOYO-1. A 3D rendering of the overlay 
images of YOYO-1 stained eDNA (green) and Nile Red stained membrane (red) is shown in left 
panel; YOYO-1 staining of eDNA within the biofilm is shown on the right. Dashed square 
highlights a region with eDNA forming web-like structures mainly localised outside the cells. An 
enlarged image of this region is shown in lower panel as a 3D rendering of overlay (left), eDNA 
stained YOYO-1 (centre) and overlay image (right). The arrow indicates two cells apparently 
permeable to YOYO-1 dye. (C) NucB treatment of E. faecalis biofilm leads to decreased eDNA 
signal in abraded cells. Epifluorescent images of abraded cells of E. faecalis biofilm stained with 
YOYO-1 (green) and FM-595 (red). 
 
Figure 2: Detection of eDNA in model dental plaque. (A) Immunofluorescent labelling of eDNA 
in model plaque with α-DNA antibody (green) and Nile Red membrane dye (red). (B) Fluorescent 
staining of eDNA with YOYO-1 (green) and Nile Red (red). (C) eDNA visualized in cells 
harvested from model dental plaque using YOYO-1 (green) and FM5-95 (red). Cells that appear 
permeable to YOYO-1 are highlighted with an asterisk. 
 
  
Figure 3: Identification of eDNA within natural plaque found on the surface of ex vivo specimens. 
(A) FESEM images of dental plaque found on the surface of a tooth extracted due to periodontitis 
showing a multispecies microbial community. i) Mesh-like structures of extracellular material are 
apparent (arrow). ii) Ruptured cells surrounded by matrix material. Asterisks highlight cells that 
appear to have a hole in their wall. iii) Vesicles appear on the surface of many cells throughout the 
biofilm (dashed square). (B) Visualization of eDNA with YOYO-1 (green) in cells harvested from 
supragingival (provisional resin composite crowns; top panel) or subgingival (overdenture 
abutments of dental implants; lower panel) regions of dental implants recovered during the 
restorative phase of implant treatment. FM5-95 membrane stain was utilised to highlight cell 
boundaries (red). (C) YOYO-1 and FM5-95 stained subgingival dental plaque isolated from the 
surface of an extracted tooth from a periodontal patient shows presence of eDNA. Treatment of 
the dental plaque with NucB prior to staining decreased the eDNA signal (green). 
 
Figure 4: Impact of NucB on salivary microcosm biofilms. Biofilms were cultured on the surface 
of glass slides (A) or microtitre plates (B). (A) Biofilms cultured in the absence or presence of 
NucB were stained with BacLight LIVE:DEAD stain and visualized by CLSM. 3D renderings 
(left) or maximum projection images (right) are shown. Live cells stained with Syto 9 appear green; 
red staining shows eDNA or compromised cells that have taken up propidium iodide. Images were 
quantified using COMSTAT and the mean +/- standard errors of biovolume or average thickness 
from three independent controls and NucB-treated samples are shown in the table. The total 
biovolume was significantly lower in NucB-treated samples than control (p<0.05, indicated by an 
asterisk). (B) Biofilms formed from the microorganisms present in four different individuals (1-4) 
or in pooled saliva were quantified by staining with crystal violet. Dark bars show controls without 
  
NucB treatment, white bars represent biofilm cultured in the presence or NucB (inhibition assays) 
or biofilms treated with NucB after culturing (dispersal). Bars represent means from three 
independent experiments and standard errors are shown. 
 
Figure 5: Microbial population shifts caused by the presence of NucB during growth. (A) Sixteen 
genera were present at >1% of the population in control (untreated) samples. Treatment with NucB 
reduced the total microbial population and shifted the composition of different genera. To facilitate 
comparison with the control, normalised data are shown on the right. These were obtained by 
multiplying all ‘NucB-treated’ values by a constant so that the total number of reads was the same 
as the control. (B) Proportions of the major species present in control samples (red circles) or 
NucB-treated samples (blue circles). Circles represent mean values from three independent 
experiments and 95% CIs are shown. Red asterisks indicate species that were present in 
significantly different proportions following NucB treatment compared with controls. 
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1. Biofilm culture and crystal violet staining 
Biofilms for crystal violet assays or for microbial population analysis were cultured 
directly on the surface of Cellstar® 96-well microtiter plates or 6-well tissue culture plates (Greiner 
Bio-one, Stonehouse, UK). Alternatively, for experiments involving microscopy, biofilms were 
grown on sterile 13 mm diameter glass coverslips. Biofilms were cultured for 24 h at 37°C 
aerobically or anaerobically, in a 90% N2/5% H2/5% CO2 environment (Bug Box Plus, Baker 
Ruskinn, Sanford, Maine, USA). For quantification of biomass, biofilms were submerged in 
100 µL of 0.5% (w/v) crystal violet. After incubation at 20°C for 15 min, wells were washed three 
times in 200 µL of PBS, air-dried, and residual crystal violet was dissolved with 100 µL of 7% 
(v/v) acetic acid and quantified by measuring A570. 
For microbial population analysis, biofilms were cultured for 24 h at 37°C in the presence 
or absence of purified NucB. Medium was discarded and biofilms were harvested in 1 ml PBS 
using a tissue culture scraper. Cells were pelleted by centrifugation for 10 min at 4°C and 3,800 g. 
DNA was extracted by incubation in 150 l spheroplasting buffer containing 37.5 µg lysozyme 
and 50 U mutanolysin (Sigma-Aldrich), and purified with the MasterPure™ Gram Positive DNA 
Purification Kit (Epicentre® Biotechnologies, Madison, USA). 
 
2. Fluorescent staining and microscopy 
Immunofluorescent labelling of eDNA was performed as described by Barnes et al. (2012). 
Briefly, samples were blocked with 2% bovine serum albumin in Hanks’ Buffered Saline Solution 
(HBSS) and labelled with a mouse anti-dsDNA monoclonal antibody (Abcam). After primary 
labelling and repeated washings with HBSS containing 0.5% bovine serum albumin, Alexa Fluor 
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488-conjugated secondary antibody was added. Alternatively, eDNA was stained with the cell-
impermeant fluorescent dye YOYO-1. Biofilm-harboring substrata were incubated with 2.4 nM 
YOYO-1 (Life Technologies) for 10 min at 20°C. To visualize cell membranes in intact biofilms, 
the biofilm-harboring substrata were incubated with 1 µg ml-1 Nile Red (Sigma-Aldrich) for 30 
min at 20°C prior to visualization. Alternatively, to visualize the cell membrane of cells removed 
from the biofilm, cells were spotted on a 1.5% (w/v) agarose pad containing 2.9 µg ml-1 FM5-95 
(Life Technologies). Live and dead cells within microcosm biofilms were stained with Live/Dead 
BacLightTM stain (Molecular Probes).  
For confocal laser scanning microscopy (CLSM), labelled or stained coverslips were rinsed 
with PBS and inverted onto a PBS filled rubber frame secured on a microscope slide. Imaging was 
performed using a Nikon A1R confocal laser scanning microscope fitted with CFI PLAN APO 
VC objective (Nikon 60x/1.40 Oil). Images were captured with NIS-Elements C (v4.4, Nikon) 
software and processed using Imaris (v8.2, Bitplane) software. Epifluorescent microscopy was 
performed on an inverted epifluorescence microscope (Zeiss Axiovert 200M) fitted with a Plan-
Neofluor objective (Zeiss 100×/1.30 Oil Ph3). A GFP filter (460/500 nm excitation 510/560 nm 
emission) was employed for visualization of YOYO-1 and a TRITC filter (excitation 528/556 nm; 
emission 571/616 nm) was used for FM5-95. Digital images were acquired and analyzed using 
METAMORPH software (V.6.2r6, Molecular Devices, Sunnyvale, CA, USA) or other programs 
as described below. 
To measure fluorescence intensity of eDNA, ImageJ software (Schneider et al. 2012) was 
used as described by McCloy et al. (2014) and modified to fit the purposes of this work. In brief, 
an entire image was selected using the box tool. Manually determined thresholding was applied to 
remove very bright foci resulting from intracellular accumulation of dye. The mean fluorescence 
4 
 
(mean gray value) was measured for 8 independent fields of view for each sample. In a similar 
manner, background reading was determined from dark areas within several different fields and 
averaged. The average background reading was subtracted from fluorescence intensity readings 
obtained from each image. The statistical significance of differences between fluorescence 
intensities of untreated and NucB-treated samples was determined using Student’s t test.  
For quantification of biofilms in CSLM images, the images were first rendered in Imaris 
software (Bitplane, Zurich, Switzerland). Image stacks were imported into ImageJ (Schneider et 
al. 2012) and analyzed using the COMSTAT2 plugin (Heydorn et al. 2000).   Three independent 
samples were quantified for each condition (untreated and NucB-treated). Differences between 
untreated and NucB-treated samples were assessed for significance using Student’s t test. 
 
3. Purification and analysis of recombinant NucB. 
 NucB was expressed in a B. subtilis expression system as described in the Methods. Crude 
NucB was used as described by Shields et al. (2013). Alternatively, secreted NucB secreted was 
precipitated from cell-free spent growth medium by making it 65% saturated with ammonium 
sulphate and incubating for 15 h at 60°C. NucB was recovered as a pellet by centrifugation at 
10,000 g for 60 min at 40°C. The NucB-containing pellet was dissolved in minimum volume of 
50 mM potassium phosphate pH 7.2, 1 mM dithiothreitol (buffer 1). All subsequent 
chromatography steps were performed at 60°C. Following clarification by centrifugation at 10,000 
g for 60 min at 40°C, the soluble protein was dialyzed against buffer 1 at 60°C and loaded onto a 
Q sepharose column previously equilibrated with buffer 1. Following a wash with buffer 1, the 
sample flow through and column wash were collected as individual fractions and assayed by SDS 
PAGE (12% separating gel) for the presence of NucB. NucB-containing fractions were pooled 
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appropriately and loaded onto a hydroxyapatite column previously equilibrated with buffer 1. The 
column was washed with buffer 1 and the sample flow through and column wash were collected 
as individual fractions. Following assay of individual fractions by SDS PAGE (12% separating 
gel) and UV absorbance spectrum, NucB-containing fractions were pooled appropriately. Using 
this procedure 50 mg of NucB at >95% purity was routinely recovered from a starting cell culture 
volume of 10 L. 
The purity of NucB was assessed using multiple independent and complementary methods. 
The presence of any nucleic acid contamination was assessed by measuring the UV absorption 
spectrum from 400 – 240 nm.  Preparations had a typical A260/A280 ratio of 0.57 (+/- 0.2) indicating 
an absence of nucleic acid contamination. Purity in terms of protein content was assessed by 
overloading an SDS PAGE gel (Fig. S2A) and by differential scanning calorimetry analysis, which 
showed a single well defined thermal unfolding transition with a typical Tm in Tris-HCl pH 8.0 of 
57.1°C (+/- 0.3°C). To ensure that the single band seen in overloaded SDS PAGE analysis 
consisted only of NucB, bands were cut from acrylamide gels, the protein was eluted from the gel 
slices and subject to peptide mass fingerprinting after digestion with trypsin. Analysis carried out 
using the MASCOT program showed that only a single protein was present that had a significant 
match in the protein database. This protein was NucB and had a protein score of 152. The protein 
score is -10*Log(P), where P is the probability that the observed match is a random event and, in 
this experiment, protein scores greater than 83 are significant (p<0.05). A further indication of 
purity of NucB was provided by the observation that purified NucB crystallized under defined 
conditions thereby facilitating determination of its structure (manuscript in preparation). 
 
4. Next generation sequencing and data analysis. 
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For next generation DNA sequencing on the Illumina MiSeq platform, the 16S rRNA gene 
V4 variable region was amplified using PCR primers 515/806 with a barcode on the forward 
primer.  Up to 100 samples were pooled, purified and used to prepare a DNA library. Sequences 
obtained were initially processed using a custom MR DNA analysis pipeline (MR DNA, 
Shallowater, TX, USA).  Sequences were joined and depleted of barcodes. Sequences <150bp and 
sequences with ambiguous base calls were removed.  Data were denoised, operational taxonomic 
units (OTUs) were defined by clustering at 3% divergence (97% similarity) and chimeras were 
removed.  Final OTUs were taxonomically classified using BLASTn against a curated database 
derived from NCBI, RDPII and GreenGenes (DeSantis et al. 2006). Differences between the 
proportions of genera and species in biofilms following NucB treatment compared with controls 
were assessed for statistical significance using T-tests with a Benjamini-Hochberg false discovery 
rate (FDR) correction set at α = 0.05 (Reiner et al. 2003). 
Alpha diversity was estimated using the Shannon-Weaver index. Shannon-Weaver was 
calculated after randomly selecting 10,000 reads for each sample. This process was bootstrapped 
over 100 iterations with read replacement. The average Shannon-Weaver score for each sample 
was calculated and grouped by presence or absence of NucB. A Kruskal-Wallis non-parametric 
test was performed to determine differences in Shannon-Weaver score between NucB-treated 
biofilms and biofilms developed in the absence of NucB. Significance threshold was set at α=0.05. 
Beta diversity was visualized on a principle coordinates analysis (PCoA) ordination plot using 
Bray-Curtis distances. Samples were rarefied to even depth according to the sample with the lowest 
read count. The OTU table was then fed as input in Phyloseq’s ordinate function in R in order to 
reduce dimensionality down to 2, where the x-axis explains the most variation attributable to 
community taxa distribution by sample, and the y-axis explains the second most variation. A visual 
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determination was used to conclude whether biofilms treated with NucB can be distinguished from 
biofilms not treated with NucB. Raw data from Illumina sequencing are stored on the Illumina 





Supplementary Figure 1 
 
Figure S1. Effects of NucB on saliva microcosm biofilms formed aerobically in the presence 
of sucrose. Biofilms were cultured from salivary inocula of 6 different volunteers in the presence 
of NucB (‘inhibition’; upper panel) or pre-formed biofilms were incubated with NucB (‘dispersal’; 
lower panel). Biofilms were quantified by staining with crystal violet and reading A570. Mean and 
standard error of control samples (dark bars) or NucB-treated samples (white bars) are shown. 
Significant difference (p<0.05) between NucB treated sample and matched control is indicated by 
an asterisk.     
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Supplementary Figure 2 
 
Figure S2. NucB purification and enzyme activity. The purity of NucB (~12 kDa) preparations 
was assessed by SDS PAGE and staining with Coomassie Brilliant Blue, loaded with different 
amounts of protein (A). B: DNase activity of NucB (N) against calf thymus DNA was compared 
with a negative control (-) and DNase I (labelled ‘D’). C: RNase activity of NucB against purified 
total bacterial RNA from Veillonella parvula, compared with RNase A (R). The 23S and 16S 
rRNA bands are indicated. D: Protease activity of NucB against bovine serum albumin compared 








Figure S3. Alpha diversity in microcosm biofilms treated with PBS (control) or NucB. The 
Shannon Weaver Index was calculated as described in the Methods. The alpha diversity of biofilms 








Figure S4. Between-sample (beta) diversity of the six individual microcosm biofilms, 
estimated by PCoA using Bray-Curtis distances. Control (PBS-treated) microcosm biofilms 
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